431 related articles for article (PubMed ID: 18268199)
1. Acute disseminating encephalomyelitis in neuromyelitis optica: closing the floodgates.
Eichel R; Meiner Z; Abramsky O; Gotkine M
Arch Neurol; 2008 Feb; 65(2):267-71. PubMed ID: 18268199
[TBL] [Abstract][Full Text] [Related]
2. Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders.
Magaña SM; Matiello M; Pittock SJ; McKeon A; Lennon VA; Rabinstein AA; Shuster E; Kantarci OH; Lucchinetti CF; Weinshenker BG
Neurology; 2009 Feb; 72(8):712-7. PubMed ID: 19237699
[TBL] [Abstract][Full Text] [Related]
3. Brain abnormalities in neuromyelitis optica.
Pittock SJ; Lennon VA; Krecke K; Wingerchuk DM; Lucchinetti CF; Weinshenker BG
Arch Neurol; 2006 Mar; 63(3):390-6. PubMed ID: 16533966
[TBL] [Abstract][Full Text] [Related]
4. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.
Pittock SJ; Weinshenker BG; Lucchinetti CF; Wingerchuk DM; Corboy JR; Lennon VA
Arch Neurol; 2006 Jul; 63(7):964-8. PubMed ID: 16831965
[TBL] [Abstract][Full Text] [Related]
5. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders.
Banwell B; Tenembaum S; Lennon VA; Ursell E; Kennedy J; Bar-Or A; Weinshenker BG; Lucchinetti CF; Pittock SJ
Neurology; 2008 Jan; 70(5):344-52. PubMed ID: 18094334
[TBL] [Abstract][Full Text] [Related]
6. [Clinical features of NMO according to brain MRI findings].
Shimizu Y
Brain Nerve; 2010 Sep; 62(9):933-43. PubMed ID: 20844304
[TBL] [Abstract][Full Text] [Related]
7. Neuromyelitis optica IgG status in acute partial transverse myelitis.
Scott TF; Kassab SL; Pittock SJ
Arch Neurol; 2006 Oct; 63(10):1398-400. PubMed ID: 17030654
[TBL] [Abstract][Full Text] [Related]
8. NMO-IgG predicts the outcome of recurrent optic neuritis.
Matiello M; Lennon VA; Jacob A; Pittock SJ; Lucchinetti CF; Wingerchuk DM; Weinshenker BG
Neurology; 2008 Jun; 70(23):2197-200. PubMed ID: 18434643
[TBL] [Abstract][Full Text] [Related]
9. "Cloud-like enhancement" is a magnetic resonance imaging abnormality specific to neuromyelitis optica.
Ito S; Mori M; Makino T; Hayakawa S; Kuwabara S
Ann Neurol; 2009 Sep; 66(3):425-8. PubMed ID: 19798642
[TBL] [Abstract][Full Text] [Related]
10. Neuromyelitis optica immunoglobulins as a marker of disease activity and response to therapy in patients with neuromyelitis optica.
Weinstock-Guttman B; Miller C; Yeh E; Stosic M; Umhauer M; Batra N; Munschauer F; Zivadinov R; Ramanathan M
Mult Scler; 2008 Sep; 14(8):1061-7. PubMed ID: 18573816
[TBL] [Abstract][Full Text] [Related]
11. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.
Hinson SR; McKeon A; Fryer JP; Apiwattanakul M; Lennon VA; Pittock SJ
Arch Neurol; 2009 Sep; 66(9):1164-7. PubMed ID: 19752309
[TBL] [Abstract][Full Text] [Related]
12. Extensive hemispheric lesions with radiological evidence of blood-brain barrier integrity in a patient with neuromyelitis optica.
Saiki S; Ueno Y; Moritani T; Sato T; Sekine T; Kawajiri S; Adachi S; Yokoyama K; Tomizawa Y; Motoi Y; Hattori N
J Neurol Sci; 2009 Sep; 284(1-2):217-9. PubMed ID: 19497587
[TBL] [Abstract][Full Text] [Related]
13. Recurrent neuromyelitis optica in Brazilian patients: clinical, immunological, and neuroimaging characteristics.
Adoni T; Lino AM; da Gama PD; Apóstolos-Pereira SL; Marchiori PE; Kok F; Callegaro D
Mult Scler; 2010 Jan; 16(1):81-6. PubMed ID: 19995833
[TBL] [Abstract][Full Text] [Related]
14. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.
Takahashi T; Fujihara K; Nakashima I; Misu T; Miyazawa I; Nakamura M; Watanabe S; Shiga Y; Kanaoka C; Fujimori J; Sato S; Itoyama Y
Brain; 2007 May; 130(Pt 5):1235-43. PubMed ID: 17449477
[TBL] [Abstract][Full Text] [Related]
15. NMO-IgG positive neuromyelitis optica in a patient with myasthenia gravis but no thymectomy.
Kay CS; Scola RH; Lorenzoni PJ; Jarius S; Arruda WO; Werneck LC
J Neurol Sci; 2008 Dec; 275(1-2):148-50. PubMed ID: 18703206
[TBL] [Abstract][Full Text] [Related]
16. Brain magnetic resonance imaging findings in acute relapses of neuromyelitis optica spectrum disorders.
Cabrera-Gómez J; Saiz-Hinarejos A; Graus F; González-Quevedo A; Rodríguez-Rojas R; Quevedo-Sotolongo L; Real-González Y; Grass-Fernández D; Cristófol-Corominas M; Rodríguez-Cordero M; Robinson-Agramonte M; Infante-Velázquez E; Cabrera-Núñez A; Ugarte-Sánchez C; Jordán-González J; González de la Nuez J; García-Lahera J; Tellez R; Baez-Martín M; Romero-García K
Mult Scler; 2008 Mar; 14(2):248-51. PubMed ID: 18208893
[TBL] [Abstract][Full Text] [Related]
17. Aquaporin-4 autoantibodies in a paraneoplastic context.
Pittock SJ; Lennon VA
Arch Neurol; 2008 May; 65(5):629-32. PubMed ID: 18474738
[TBL] [Abstract][Full Text] [Related]
18. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo.
Bradl M; Misu T; Takahashi T; Watanabe M; Mader S; Reindl M; Adzemovic M; Bauer J; Berger T; Fujihara K; Itoyama Y; Lassmann H
Ann Neurol; 2009 Nov; 66(5):630-43. PubMed ID: 19937948
[TBL] [Abstract][Full Text] [Related]
19. Comparison of deep gray matter lesions on magnetic resonance imaging among adults with acute disseminated encephalomyelitis, multiple sclerosis, and neuromyelitis optica.
Zhang L; Wu A; Zhang B; Chen S; Men X; Lin Y; Lu Z
Mult Scler; 2014 Apr; 20(4):418-23. PubMed ID: 23886831
[TBL] [Abstract][Full Text] [Related]
20. Occurrence of acute large and edematous callosal lesions in neuromyelitis optica.
Nakamura M; Misu T; Fujihara K; Miyazawa I; Nakashima I; Takahashi T; Watanabe S; Itoyama Y
Mult Scler; 2009 Jun; 15(6):695-700. PubMed ID: 19435750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
